Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hepatitis A Antibodies"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 377
Tytuł:
Seroprevalence of hepatitis A virus antibodies among children and adolescents living in Northern Thailand: an implication for hepatitis A immunization.
Autorzy:
Kunanitthaworn N; Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Mueangmo O; Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.; Clinical and Molecular Epidemiology of Emerging and Re-emerging Infectious Diseases Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Saheng J; Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.; Clinical and Molecular Epidemiology of Emerging and Re-emerging Infectious Diseases Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Wongjak W; Clinical and Molecular Epidemiology of Emerging and Re-emerging Infectious Diseases Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Lertsiriladakul T; Clinical and Molecular Epidemiology of Emerging and Re-emerging Infectious Diseases Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Chaito T; Clinical and Molecular Epidemiology of Emerging and Re-emerging Infectious Diseases Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Nantarat P; Clinical and Molecular Epidemiology of Emerging and Re-emerging Infectious Diseases Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Sudjaritruk T; Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. .; Clinical and Molecular Epidemiology of Emerging and Re-emerging Infectious Diseases Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 13; Vol. 13 (1), pp. 17432. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis A virus*
Hepatitis A*/epidemiology
Hepatitis A*/prevention & control
Humans ; Male ; Child ; Adolescent ; Female ; Hepatitis A Antibodies ; Seroepidemiologic Studies ; Thailand/epidemiology ; Cross-Sectional Studies ; Overweight ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Masitinib Inhibits Hepatitis A Virus Replication.
Autorzy:
Sasaki-Tanaka R; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Shibata T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Moriyama M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Kogure H; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Hirai-Yuki A; Division of Experimental Animal Research, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
Okamoto H; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Shimotsuke, Tochigi 329-0498, Japan.
Kanda T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 03; Vol. 24 (11). Date of Electronic Publication: 2023 Jun 03.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis A*/drug therapy
Hepatitis A virus*/genetics
Humans ; Hepatitis A Antibodies ; Protein Biosynthesis ; RNA, Viral/genetics ; Virus Replication/genetics ; Subgenomic RNA/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence of total hepatitis A antibody among 5 to 7 years old children and their mothers in Cambodia.
Autorzy:
Nagashima S; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Ko K; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Yamamoto C; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Bunthen E; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Payment Certification Agency, Ministry of Health of Cambodia, Phnom Penh, Cambodia.
Ouoba S; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Unité de Recherche Clinique de Nanoro (URCN), Nanoro, Burkina Faso.
Chuon C; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Faculty of Medicine, University of Puthisastra, Phnom Penh, Cambodia.
Ohisa M; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Sugiyama A; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Akita T; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Hossain MS; Expanded Programme On Immunization, World Health Organization Country Office, Phnom Penh, Cambodia.
Ork V; National Immunization Programme, Ministry of Health, Phnom Penh, Cambodia.
Mao B; University of Health Sciences, Phnom Penh, Cambodia.
Tanaka J; Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Feb 26; Vol. 11 (1), pp. 4778. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis A/*blood
Hepatitis A Antibodies/*blood
Hepatitis A Virus, Human/*isolation & purification
Cambodia/epidemiology ; Child ; Child, Preschool ; Female ; Hepatitis A/epidemiology ; Hepatitis A/immunology ; Hepatitis A Antibodies/immunology ; Hepatitis A Virus, Human/immunology ; Humans ; Male ; Prevalence ; Seroepidemiologic Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hepatitis A virus infection in Brazilian correctional facilities.
Autorzy:
Castro LS; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.; Universidade Federal de Rondonópolis, Rondonópolis, Mato Grosso, Brazil.
de Rezende GR; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Puga MAM; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Bandeira LM; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Ortiz Tanaka TS; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Weis-Torres S; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Taira DL; Laboratório Central de Saúde Pública de Mato Grosso do Sul/SES/MS, Campo Grande, Mato Grosso do Sul, Brazil.
Demarchi LHF; Laboratório Central de Saúde Pública de Mato Grosso do Sul/SES/MS, Campo Grande, Mato Grosso do Sul, Brazil.
Croda JRH; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Mato Grosso do Sul, Brazil.
Pinho JRR; LIM-07, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Gomes-Gouvêa MS; LIM-07, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Motta-Castro ARC; Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Mato Grosso do Sul, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 25; Vol. 18 (4), pp. e0283868. Date of Electronic Publication: 2023 Apr 25 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis A virus*
Hepatitis A*
Humans ; Hepatitis A Antibodies ; Brazil/epidemiology ; Cross-Sectional Studies ; Seroepidemiologic Studies ; Prevalence ; Correctional Facilities ; Immunoglobulin M
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Serosurvey of hepatitis A virus and E virus infection among municipal sweepers working in the largest city in the south of Iran.
Autorzy:
Hosseini SY; Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Joharinia N; Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Hosseini SA; Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Firoozi Ghahestani S; Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghojoghi R; Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Dorost K; Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Moghadami M; Department of Internal Medicine, Namazi Hospital, Shiraz, Iran.
Gheshlaghi A; Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Jaberi O; Occupational Health Engineering, HSE Unit, Shiraz Waste Management Organization, Shiraz, Iran.
Khoshbakht R; Occupational Health Engineering, HSE Unit, Shiraz Waste Management Organization, Shiraz, Iran.
Sarvari J; Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.; Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Pokaż więcej
Źródło:
Journal of immunoassay & immunochemistry [J Immunoassay Immunochem] 2022 Sep 03; Vol. 43 (5), pp. 493-501. Date of Electronic Publication: 2022 Mar 26.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis A*/epidemiology
Hepatitis A virus*
Hepatitis E*/epidemiology
Hepatitis E virus*
Adult ; Cross-Sectional Studies ; Female ; Hepatitis A Antibodies ; Humans ; Immunoglobulin G ; Immunoglobulin M ; Iran/epidemiology ; Male ; Middle Aged ; Prevalence ; Seroepidemiologic Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking.
Autorzy:
Sasaki-Tanaka R; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Nagulapalli Venkata KC; Department of Pharmaceutical and Administrative Sciences, Saint Louis College of Pharmacy, University of Health Sciences and Pharmacy, St. Louis, MO 63010, USA.
Okamoto H; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi 329-0498, Japan.
Moriyama M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Kanda T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 May 27; Vol. 23 (11). Date of Electronic Publication: 2022 May 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Hepatitis A*/drug therapy
Hepatitis A virus*/genetics
Liver Neoplasms*/drug therapy
3C Viral Proteases ; Hepatitis A Antibodies ; Humans ; Molecular Docking Simulation ; Protease Inhibitors/pharmacology ; Virus Replication
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Special Issue "Recent Progress in Hepatitis A Virus Research".
Autorzy:
Lhomme S; Virology Laboratory, Hôpital Purpan, CHU Toulouse, 31300 Toulouse, France.; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291-CNRS UMR5051, 31300 Toulouse, France.; Université Toulouse III Paul-Sabatier, 31062 Toulouse, France.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 May 25; Vol. 14 (6). Date of Electronic Publication: 2022 May 25.
Typ publikacji:
Editorial
MeSH Terms:
Hepatitis A*/prevention & control
Hepatitis A virus*/genetics
Hepatitis, Viral, Human*/prevention & control
Acute Disease ; Hepatitis A Antibodies ; Humans ; Vaccines, Inactivated
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Very low prevalence of anti-HAV in Japan: high potential for future outbreak.
Autorzy:
Yamamoto C; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ko K; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Nagashima S; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Harakawa T; Hiroshima Community Health Promotion Organization, Hiroshima Prefecture, Hiroshima, Japan.
Fujii T; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Hiroshima Community Health Promotion Organization, Hiroshima Prefecture, Hiroshima, Japan.
Ohisa M; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Katayama K; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Takahashi K; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Department of Medical Sciences, Tokyo Shinagawa Hospital, Tokyo, Japan.
Okamoto H; Division of Virology, Department of Infection and Immunity, Jichi Medical University, School of Medicine, Tochigi, Japan.
Tanaka J; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Feb 06; Vol. 9 (1), pp. 1493. Date of Electronic Publication: 2019 Feb 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis A Antibodies/*analysis
Hepatitis A Virus, Human/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Disease Outbreaks ; Female ; Hepatitis A/epidemiology ; Hepatitis A Antibodies/immunology ; Hepatitis A virus/immunology ; Hepatitis A virus/pathogenicity ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Prevalence ; Risk Factors ; Seroepidemiologic Studies ; Serologic Tests/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes.
Autorzy:
Sasaki-Tanaka R; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Shibata T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Okamoto H; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke-shi 329-0498, Japan.
Moriyama M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Kanda T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Feb 27; Vol. 23 (5). Date of Electronic Publication: 2022 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis A*
Hepatitis A virus*/genetics
Amides ; Hepatitis A Antibodies/therapeutic use ; Hepatocytes ; Humans ; Nucleotides ; Pyrazines ; RNA, Viral/genetics ; Ribavirin/therapeutic use ; Virus Replication
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term persistence of anti-HAV antibody conferred by a single dose of live-attenuated hepatitis A vaccine: Results from 17-year follow-up.
Autorzy:
Chen Y; Key Laboratory of Medical Molecular Virology of MoE & MoH and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Zhao YL; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Hao ZY; Zhengding County Center for Disease Control and Prevention, Zhengding, Hebei, China.
Zhang XJ; Zhengding County Center for Disease Control and Prevention, Zhengding, Hebei, China.
Ma JC; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Zhang ZY; Zhengding County Center for Disease Control and Prevention, Zhengding, Hebei, China.
Zhang YH; Zhengding County Center for Disease Control and Prevention, Zhengding, Hebei, China.
Zhao G; Key Laboratory of Medical Molecular Virology of MoE & MoH and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Qiu C; Key Laboratory of Medical Molecular Virology of MoE & MoH and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Kilgore PE; Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
Wang SM; Laboratory of Molecular Biology, Training Center of Medical Experiments, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Wang XY; Key Laboratory of Medical Molecular Virology of MoE & MoH and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.; Children's Hospital, Fudan University, Shanghai, China.; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2021 Dec; Vol. 28 (12), pp. 1751-1755. Date of Electronic Publication: 2021 Aug 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis A*/epidemiology
Hepatitis A*/prevention & control
Hepatitis A Vaccines*
Follow-Up Studies ; Hepatitis A Antibodies ; Humans ; Immunization, Secondary
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Hepatitis A Virus Incidence Rates and Biomarker Dynamics for Plasma Donors, United States.
Autorzy:
Schoch S
Wälti M
Schemmerer M
Alexander R
Keiner B
Kralicek C
Bycholski K
Hyatt K
Knowles J
Klochkov D
Simon T
Wenzel JJ
Roth NJ
Widmer E
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2021 Nov; Vol. 27 (11), pp. 2718-2824.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis A*/diagnosis
Hepatitis A*/epidemiology
Hepatitis A virus*/genetics
Biomarkers ; Disease Outbreaks ; Hepatitis A Antibodies ; Humans ; Incidence ; United States/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Nationwide seroprevalence of hepatitis A in South Korea from 2009 to 2019.
Autorzy:
Lee DY; Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Osong, Republic of Korea.
Chae SJ; Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Osong, Republic of Korea.
Cho SR; Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Osong, Republic of Korea.
Choi W; Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Osong, Republic of Korea.
Kim CK; Seoul Clinical Laboratories, Yongin, Republic of Korea.
Han MG; Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Osong, Republic of Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Feb 08; Vol. 16 (2), pp. e0245162. Date of Electronic Publication: 2021 Feb 08 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis A/*epidemiology
Female ; Hepatitis A Antibodies/analysis ; Hepatitis A Antibodies/immunology ; Hepatitis A virus/immunology ; Humans ; Longitudinal Studies ; Male ; Republic of Korea/epidemiology ; Seroepidemiologic Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of Antibodies against Hepatitis A Virus (HAV) by a Surface Plasmon Resonance (SPR) Biosensor: A New Diagnosis Tool Based on the Major HAV Capsid Protein VP1 (SPR-HAVP1).
Autorzy:
Santos GMCD; Laboratório de Desenvolvimento Tecnológico em Virologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro CEP 21040-900, Brazil.
Alves CR; Laboratório de Biologia Molecular e Doenças Endêmicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro CEP 21040-900, Brazil.
Pinto MA; Laboratório de Desenvolvimento Tecnológico em Virologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro CEP 21040-900, Brazil.
Amado Leon LA; Laboratório de Desenvolvimento Tecnológico em Virologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro CEP 21040-900, Brazil.
Souza-Silva F; Centro de Desenvolvimento Tecnológico em Saúde (CDTS), Instituto Nacional de Ciência e Tecnologia de Inovação em Doenças de Populações Negligenciadas (INCT/IDPN), Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro CEP 21040-900, Brazil.; Faculdade de Ciências Biológicas e da Saúde, Universidade Iguaçu, Avenida Abílio Augusto Távora, 2134, Dom Rodrigo, Nova Iguaçu CEP 26260-045, Brazil.
Pokaż więcej
Źródło:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2021 May 03; Vol. 21 (9). Date of Electronic Publication: 2021 May 03.
Typ publikacji:
Journal Article
MeSH Terms:
Biosensing Techniques*
Hepatitis A*/diagnosis
Hepatitis A Antibodies/*analysis
Viral Structural Proteins/*immunology
Capsid Proteins ; Hepatitis A virus ; Humans ; Immunoglobulin M ; Surface Plasmon Resonance
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hepatitis B Vaccination Coverage among Healthcare Workers and Evaluation of Immune Response by Estimating Anti-HBs Antibody Titers over Time at a Tertiary Care Hospital: A Cross-sectional Study
Autorzy:
PRIYANKA SONI
ARUNA SOLANKI
ANKITA SONI
LAXMAN KUMAR SONI
AMAN DEEP
ANKITA PORWAL
KAMINI RANAWAT
Pokaż więcej
Temat:
anti hepatitis b
hepatitis b antibodies
hepatitis b vaccines
Medicine
Źródło:
Journal of Clinical and Diagnostic Research, Vol 18, Iss 01, Pp 01-05 (2024)
Opis pliku:
electronic resource
Relacje:
https://www.jcdr.net/articles/PDF/18969/66145_CE[Ra1]_QC(Shee)_F&Ref(SS)_PF1(AG_KM)_PFA(AG_OM)_PN(KM).pdf; https://doaj.org/toc/2249-782X; https://doaj.org/toc/0973-709X
Dostęp URL:
https://doaj.org/article/c6a62f3ed9194e78aeb38cd207d85e2d  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients.
Autorzy:
Prasoppokakorn T; Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Vanichanan J; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Chaiteerakij R; Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Center of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Jutivorakool K; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Udomkarnjananun S; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Excellence Center for Solid Organ Transplantation, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Renal Immunology and Renal Transplant Research Unit, Chulalongkorn University, Bangkok, Thailand.
Pongpirul K; Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Taesombat W; Excellence Center for Solid Organ Transplantation, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Department of Surgery, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Wattanatorn S; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Avihingsanon Y; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Renal Immunology and Renal Transplant Research Unit, Chulalongkorn University, Bangkok, Thailand.
Tungsanga K; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Eiam-Ong S; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Praditpornsilpa K; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Townamchai N; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand. .; Excellence Center for Solid Organ Transplantation, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. .; Renal Immunology and Renal Transplant Research Unit, Chulalongkorn University, Bangkok, Thailand. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jan 08; Vol. 11 (1), pp. 50. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis A Vaccines/*administration & dosage
Kidney Transplantation/*adverse effects
Adolescent ; Adult ; Aged ; Dose-Response Relationship, Immunologic ; Drug Administration Schedule ; Female ; Hepatitis A/prevention & control ; Hepatitis A Antibodies/immunology ; Hepatitis A Vaccines/therapeutic use ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
First evidence for continuous circulation of hepatitis A virus subgenotype IIA in Central Africa.
Autorzy:
Abe H; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
Ushijima Y; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
Bikangui R; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
Ondo GN; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Zadeh VR; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.; Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Pemba CM; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.; Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Mpingabo PI; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.; Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Igasaki Y; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
de Vries SG; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Division of Internal Medicine, Department of Infectious Diseases, Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Grobusch MP; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.; Division of Internal Medicine, Department of Infectious Diseases, Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Loembe MM; Université des Sciences de la Santé de Libreville, Libreville, Gabon.
Agnandji ST; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
Lell B; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Yasuda J; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.; Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.; National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, Nagasaki, Japan.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2020 Nov; Vol. 27 (11), pp. 1234-1242. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis A*/immunology
Hepatitis A virus*/isolation & purification
Africa, Central ; Child ; Female ; Gabon ; Genotype ; Hepatitis A Antibodies ; Humans ; Male ; Phylogeny ; Seroepidemiologic Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High prevalence of hepatitis A in indigenous population in north Brazil.
Autorzy:
de Paula VS; Molecular Virology Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
Milagres FAP; Federal University of Tocantins, UFT, Tocantins, Brazil.
Oliveira GM; Cancer Nacional Institute, INCA, Rio de Janeiro, Brazil.
Miguel JC; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Helio and Peggy Pereira Pavillion, Ground Floor, Room B09, FIOCRUZ Av. Brasil, 4365 - Manguinhos, Rio de Janeiro, 210360-040, Brazil.
Cruz HM; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Helio and Peggy Pereira Pavillion, Ground Floor, Room B09, FIOCRUZ Av. Brasil, 4365 - Manguinhos, Rio de Janeiro, 210360-040, Brazil.
Scalioni LP; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Helio and Peggy Pereira Pavillion, Ground Floor, Room B09, FIOCRUZ Av. Brasil, 4365 - Manguinhos, Rio de Janeiro, 210360-040, Brazil.; Hepatology Research Group, University of Plymouth, Plymouth, Devon, UK.
Marques VA; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Helio and Peggy Pereira Pavillion, Ground Floor, Room B09, FIOCRUZ Av. Brasil, 4365 - Manguinhos, Rio de Janeiro, 210360-040, Brazil.
Magalhães MAFM; Laboratory of Information in Health, Institute of Communication and Technological and Scientific Information in Health (ICICT), FIOCRUZ, Rio de Janeiro, Brazil.
Romão AR; Laboratory of Information in Health, Institute of Communication and Technological and Scientific Information in Health (ICICT), FIOCRUZ, Rio de Janeiro, Brazil.
Gracie R; Laboratory of Information in Health, Institute of Communication and Technological and Scientific Information in Health (ICICT), FIOCRUZ, Rio de Janeiro, Brazil.
Villar LM; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Helio and Peggy Pereira Pavillion, Ground Floor, Room B09, FIOCRUZ Av. Brasil, 4365 - Manguinhos, Rio de Janeiro, 210360-040, Brazil. .
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2020 Sep 29; Vol. 13 (1), pp. 458. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis A*/epidemiology
Adult ; Brazil/epidemiology ; Hepatitis A Antibodies ; Humans ; Male ; Population Groups ; Prevalence ; Seroepidemiologic Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact.
Autorzy:
Ayouni K; Laboratory of Clinical Virology - Pasteur Institute of Tunis, University of Tunis El Manar, 13, Place Pasteur, BP: 74-1002, Tunis, Tunisia. .; Clinical Investigation Center - Pasteur Institute of Tunis, University of Tunis El Manar, Street 15 Medenine Bardo, Tunis, Tunisia. .; Faculty of Sciences of Tunis, University of Tunis El Manar, Campus Universitaire 2092-El Manar, Tunis, Tunisia. .
Naffeti B; Laboratory of Intelligent Networks and Nanotechnology, LARINA, University of Carthage, Tunis, Tunisia.; Faculty of Sciences of Bizerte, University of Carthage, Avenue de la République, P. O. Box 77-1054, Tunis, Amilcar, Tunisia.
Ben Aribi W; Laboratory of Intelligent Networks and Nanotechnology, LARINA, University of Carthage, Tunis, Tunisia.; Faculty of Sciences of Bizerte, University of Carthage, Avenue de la République, P. O. Box 77-1054, Tunis, Amilcar, Tunisia.
Bettaieb J; Clinical Investigation Center - Pasteur Institute of Tunis, University of Tunis El Manar, Street 15 Medenine Bardo, Tunis, Tunisia.; Department of Epidemiology - Clinical Investigation Center - Pasteur Institute of Tunis, University of Tunis El Manar, 13, Place Pasteur, BP: 74-1002, Tunis, Tunisia.; Faculty of Medicine of Tunis, University of Tunis El Manar, 15 Rue Djebel Lakhdhar. La Rabta, 1007, Tunis, Tunisia.
Hammami W; Laboratory of Clinical Virology - Pasteur Institute of Tunis, University of Tunis El Manar, 13, Place Pasteur, BP: 74-1002, Tunis, Tunisia.; Clinical Investigation Center - Pasteur Institute of Tunis, University of Tunis El Manar, Street 15 Medenine Bardo, Tunis, Tunisia.
Ben Salah A; Clinical Investigation Center - Pasteur Institute of Tunis, University of Tunis El Manar, Street 15 Medenine Bardo, Tunis, Tunisia.; Department of Epidemiology - Clinical Investigation Center - Pasteur Institute of Tunis, University of Tunis El Manar, 13, Place Pasteur, BP: 74-1002, Tunis, Tunisia.; Faculty of Medicine of Tunis, University of Tunis El Manar, 15 Rue Djebel Lakhdhar. La Rabta, 1007, Tunis, Tunisia.
Ammar H; Laboratory of Intelligent Networks and Nanotechnology, LARINA, University of Carthage, Tunis, Tunisia.; Faculty of Economic Sciences and Management of Nabeul, University of Carthage, Avenue de la République, BP 77-1054, Tunis, Amilcar, Tunisia.
Ben Miled S; Laboratory of Bioinformatics, Biomathématics and Biostatistics, Pasteur Institute of Tunis, University of Tunis El Manar, 13, Place Pasteur, BP: 74-1002, Tunis, Tunisia.
Triki H; Laboratory of Clinical Virology - Pasteur Institute of Tunis, University of Tunis El Manar, 13, Place Pasteur, BP: 74-1002, Tunis, Tunisia.; Clinical Investigation Center - Pasteur Institute of Tunis, University of Tunis El Manar, Street 15 Medenine Bardo, Tunis, Tunisia.; Faculty of Medicine of Tunis, University of Tunis El Manar, 15 Rue Djebel Lakhdhar. La Rabta, 1007, Tunis, Tunisia.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2020 Aug 26; Vol. 20 (1), pp. 627. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji:
Journal Article
MeSH Terms:
Models, Theoretical*
Hepatitis A/*epidemiology
Hepatitis A/*transmission
Hepatitis A virus/*immunology
Vaccination/*methods
Adolescent ; Adult ; Age Factors ; Aged ; Child ; Child, Preschool ; Female ; Hepatitis A/blood ; Hepatitis A/prevention & control ; Hepatitis A Antibodies/blood ; Humans ; Incidence ; Male ; Middle Aged ; Prevalence ; Seroepidemiologic Studies ; Tunisia/epidemiology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sero-prevalence of viral hepatitis A in a district of Sri Lanka: a community based cross-sectional study.
Autorzy:
Ariyarathna N; Regional Director of Health Services Office, Ministry of Health, Gampaha, Sri Lanka.
Abeysena C; Department of Public Health, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2019 May 21; Vol. 19 (1), pp. 443. Date of Electronic Publication: 2019 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis A/*epidemiology
Hepatitis A virus/*isolation & purification
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Hepatitis A/blood ; Hepatitis A/immunology ; Hepatitis A/virology ; Hepatitis A Antibodies/blood ; Hepatitis A Antibodies/immunology ; Hepatitis A virus/genetics ; Hepatitis A virus/immunology ; Humans ; Infant ; Male ; Middle Aged ; Prevalence ; Rural Population/statistics & numerical data ; Seroepidemiologic Studies ; Sri Lanka/epidemiology ; Urban Population/statistics & numerical data ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 377

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies